Accuracy Coverage Pricing Help Centre Contact

BTG 2013 Final results

Investment Tools Ltd.
BTG 2013 Final results

BTG plc: Final Results

Strong financial performance enabling continued investment in growth strategy

London, UK, 20 May 2013: BTG plc (LSE: BTG), the specialist healthcare company, today announces its final results for the year ended 31 March 2013.

Financial highlights

━ Revenue increased by 19% to £233.7m (11/12: £197.0m)

━ Underlying operating profit before acquisition adjustments and reorganisation costs of £69.0m
(11/12: £54.0m); reported operating profit of £25.7m (11/12: £19.9m)

━ Profit after tax of £16.4m (11/12: £14.6m)

━ £46.8m of cash generated, with cash and cash equivalents, together with cash on fixed term deposits, of £158.7m at 31 March 2013 (£111.9m at 31 March 2012)

Operating highlights

━ Strong performance from Specialty Pharmaceuticals

━ CroFab® (crotalidae polyvalent immune fab (ovine)) sales benefitted from normalisation of wholesaler inventories

━ DigiFab® (digoxin immune fab (ovine)) performance helped by continued geographic expansion

━ Strong US launch for Voraxaze® (glucarpidase)

━ Interventional Medicine growth plans on track

━ Varisolve® (polidocanol endovenous microfoam (PEM)) US NDA accepted for review

━ Transition to direct US sales of LC Bead delivering increased revenues, margins and contribution

━ Beads indication expansion, geographic expansion and innovation activities progressing well

━ Licensing & Biotechnology

━ Strong growth in royalties from Johnson & Johnson's Zytiga® (abiraterone acetate)

━ Sanofi/Genzyme's Lemtrada™ (alemtuzumab) under review in the US and EU for multiple sclerosis

Louise Makin, BTG's Chief Executive Officer, commented: "We have delivered strong financial results which reflect the successful transition of our business into a commercially focused, specialist healthcare company that makes and markets its own products. We are on track with our growth strategy, and are investing in our Beads business, preparing for a potential H1 2014 US approval and launch of Varisolve® and actively seeking opportunities to add new products and programmes. Overall, we have the financial resources and capabilities to continue to build the business and deliver our growth strategy."

Companies mentioned

Latest News

Investment Tools Limited

The Group is strongly capital generative, although this has been impacted by PPI in 2019. Given a strong capital position at the year end, the Lloyds Banking Board has recommended a final ordinary dividend of 2.25 pence per share, bringing the total ordinary dividend for the year to 3.37 pence per share. This represents an increase of 5 per cent on 2018 and is in line with their progressive and sustainable ordinary dividend policy. The Group's capital position remains strong with a pro forma CET1 ratio of 13.8 per cent after allowing for ordinary dividends.

Read more
Investment Tools Limited

Morgan Sindall announces their total dividend for the year has been increased by 11% to 59.0p per share (FY 2018: 53.0p), which includes a proposed increase in the final dividend of 12% to 38.0p per share (FY 2018: 34.0p), reflecting the improved result in the year, the strong balance sheet and the Board's confidence in the future prospects of the Group. The total dividend per share is 2.7 times covered by adjusted earnings per share. 

Read more
Investment Tools Limited

The BAE Systems Board has recommended a final dividend of 13.8p for a total of 23.2p for the full year. Subject to shareholder approval at the May 2020 Annual General Meeting, the dividend will be paid on 1 June 2020 to holders of ordinary shares registered on 17 April 2020.

Read more
Investment Tools Limited

The Spectris Board is proposing to pay a final dividend of 43.2 pence per share which, combined with the interim dividend of 21.9 pence, gives a total of 65.1 pence per share for the year, an increase of 6.7%. This is consistent with their policy of making progressive dividend payments based upon affordability and sustainability and represents the 30th year in succession of dividend growth. The dividend will be paid on 22 June 2020 to shareholders on the register at the close of business on 22 May 2020. The ex-dividend date is 26 May 2020.

Read more
Investment Tools Limited

In line with their policy, the Board is maintaining the interim core dividend at 1.11p per share (2018: 1.11p). The interim dividend payment date will be 9 April 2020 and the ex-dividend date is 5 March 2020 (record date 6 March 2020).

Read more
Investment Tools Limited

The Smith & Nephew Board has announced they plan to recommend a Final Dividend of 23.1¢ per share (46.2¢ per ADS). Together with an Interim Dividend of 14.4¢ per share (28.8¢ per ADS), this will give a total distribution of 37.5¢ per share (75.0¢ per ADS) for 2019, representing year-on-year growth of 4% in the declared full year dividend. The Final Dividend will be paid on 6 May 2020 to shareholders on the register at the close of business on 3 April 2020.

Read more
Investment Tools Limited

The MoneySupermarket Board has recommended a final dividend of 8.61 pence per share (2018: 8.10p), making the proposed full-year dividend 11.71 pence per share (2018: 11.05 pence per share) and reflecting their progressive dividend policy. The final dividend will be paid on 14 May 2020 to shareholders on the register on 2 April 2020, subject to approval by shareholders at the Annual General Meeting to be held on 9 May 2020.

Read more
Investment Tools Limited

Taking into account the performance of the Group's producing assets in 2019 and the outlook for 2020, the Kaz Minerals Board has recommended a final dividend of 8.0 US cents per share. Combined with the interim dividend of 4.0 US cents per share, the dividend in respect of the 2019 financial year is 12.0 US cents per share.

Read more
Investment Tools Limited

In line with the Anglo American Group's established dividend policy to pay out 40% of underlying earnings, the Board has proposed a dividend of $0.47 per share, bringing the total dividends paid and proposed in respect of 2019 to $1.09 per share (2018: $1.00 per share).

Read more
Investment Tools Limited

In light of the results for the year, the Rathbone Brothers Board has proposed a final dividend for 2019 of 45.0p. This results in a full year dividend of 70.0p, an increase of 4.0p on 2018 (6.1%). The proposed full year dividend is covered 0.7 times by basic earnings and 1.9 times by underlying earnings.

Read more
More News